Anastrozole Diamide Impurity
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

120512-04-1Anastrozole Diamide Impurity

● In Stock

Catalogue No.:VL2490003
CAS No.:120512-04-1
Mol. Formula:C17H23N5O2
Mol. Weight:329.4 g/mol

Additional information on CAS 120512-04-1

Parent drug

Anastrozole

IUPAC Name

α,α,α’,α’-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetamide

Synonyms

Anastrozole Diamide Impurity

Description

Anastrozole Diamide Impurity/Anastrozole Diamide Impurity(CAS No: 120512-04-1) or a,a,a’,a’-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetamide, it is non-steroidal aromatase inhibitor and used to treat breast cancer in women after menopause.

References

Cuzick, Jack, et al. “Anastrozole for Prevention of Breast Cancer in High-Risk Postmenopausal Women (IBIS-II): An International, Double-Blind, Randomised Placebo-Controlled Trial.” Lancet (London, England), vol. 383, no. 9922, 2014, pp. 1041–8, www.ncbi.nlm.nih.gov/pubmed/24333009, 10.1016/S0140-6736(13)62292-8. Accessed 21 Nov. 2019.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url